RE:Thank youAs with every deal, it would depend on the price paid. Short term the stock might jump regardless though. If Knight bought Paladin at 5x that adjusted net income, the stock would pop and stay there likely. If Knight bought it for 10x, I think the jump would be temporary.
I believe an analyst report found goodman usually pays about 7x P/E on acquisitions. In 2018 Paladin grew sales just 2%, so this isn't the type of company to pay up for. Endo is probably going to face cash shortfalls wiht its debt maturities starting in 2021 through 2024, but I'm not sure they'd sell Paladin for just $300 million, that wouldn't put much of a dent in the debt.